More specifically, several studies have shown association of increased circulating OPG with worsened macrovascular complications in T2DM, including coronary artery disease [55–58], carotid artery disease [58–61], and peripheral artery disease [59, 62, 63]. This evidence concerns the gene TNFRSF11B and type 2 diabetes mellitus.